Table 2 Baseline characteristics, all patients

Age, mean (range)

64.90 ± 13.94 (26–90)

64.89 ± 13.01 (39–88)

64.91 ± 17.43 (26–90)

0.997

Female, % (n)

39.6 (19)

45.9 (17)

18.2 (2)

0.161

Hospital stay, weeks, mean (range)

15.66 ± 18.30 (1–90)

18.05 ± 20.02 (1–90)

7.59 ± 6.27 (1–21)

0.264

mRS premorbid

 mRS 0–2, % (n)

83.0 (39/47)

81.1 (30/37)

90.0 (9/10)

0.667

 mRS 3–5, % (n)

17.0 (8/47)

18.9 (7/37)

10.0 (1/10)

0.667

mRS admission

 mRS 0–2, % (n)

27.1 (13/48)

24.3 (9/37)

36.4 (4/11)

0.458

 mRS 3–5, % (n)

72.9 (35/48)

75.7 (28/37)

63.6 (7/11)

0.458

mRS discharge

 mRS 0–2, % (n)

27.1 (13/48)

27.0 (10/37)

27.3 (3/11)

1.000

 mRS 3–5, % (n)

41.7 (20/48)

51.4 (19/37)

9.1 (1/11)

0.016*

In-hospital mortality, % (n)

31.3 (15)

21.6 (8)

63.6 (7)

0.022*

APT on admission, % (n)

31.3 (15)

32.4 (12)

27.3 (3)

1.000

OAC on admission, % (n)

33.3 (16)

35.1 (13)

27.3 (3)

0.729

Thrombocytopenia, % (n)

29.8 (14/47)

18.9 (7/36)

63.6 (7/11)

0.009*

IVT, % (n)

6.3 (3)

2.7 (1)

18.2 (2)

0.127

ECASS II

 HT1

11.4 (5/44)

15.2 (5/33)

0

–

 HT2

9.1 (4/44)

12.1 (4/33)

0

–

 PH1

6.8 (3/44)

0

27.3 (3/11)

–

 PH2

6.8 (3/44)

0

27.3 (3/11)

–

Stroke > 1 cerebral flow area, % (n)

56.3 (27)

51.4 (19)

72.7 (8)

0.304

MRI available, % (n)

45.8 (22)

43.2 (16)

54.5 (6)

–

Microbleeds (adjusted for MRI), % (n)

50.0 (11/22)

43.8 (7/16)

66.7 (4/6)

0.635

Staphylococcus aureus detection, % (n)

20.8 (10)

13.5 (5)

45.5 (5)

0.036*

Mitral valve, % (n)

47.9 (23)

43.2 (16)

63.6 (7)

0.311

Severe valve regurgitation (> II°), % (n)

36.2 (17/47)

35.1 (13/37)

40.0 (4/10)

1.000

Indication for surgery

62.5 (30)

64.8 (24)

54.5 (6)

–

Surgery performed, % (n)

39.6 (19)

43.2 (16)

27.3 (3)

0.488

Ischemic stroke after surgery, % (n)

15.7 (3/19)

18.8 (3/16)

0 (0/3)

–

Intracranial hemorrhage after surgery, % (n)

0 (0/19)

0 (0/16)

0 (0/3)

–